Grants and Contracts Details
Description
The goal of this trial is to examine the therapeutic effects of intranasally-administered insulin (INI) on cognition, entorhinal cortex and hippocampal atrophy, and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment (aMCI) or mild Alzheimer's disease (AD).
| Status | Finished |
|---|---|
| Effective start/end date | 3/1/13 → 4/30/16 |
Funding
- University of California San Diego Health: $19,500.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.